1. Home
  2. IRMD vs WVE Comparison

IRMD vs WVE Comparison

Compare IRMD & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iRadimed Corporation

IRMD

iRadimed Corporation

HOLD

Current Price

$92.02

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$6.04

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRMD
WVE
Founded
1992
2012
Country
United States
Singapore
Employees
166
317
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
IRMD
WVE
Price
$92.02
$6.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
16
Target Price
$116.00
$29.81
AVG Volume (30 Days)
109.3K
2.2M
Earning Date
05-01-2026
04-28-2026
Dividend Yield
0.95%
N/A
EPS Growth
16.67
N/A
EPS
0.86
N/A
Revenue
$83,814,000.00
$3,704,000.00
Revenue This Year
$12.38
N/A
Revenue Next Year
$11.31
$85.67
P/E Ratio
$106.06
N/A
Revenue Growth
14.43
149.43
52 Week Low
$67.84
$5.02
52 Week High
$107.90
$21.73

Technical Indicators

Market Signals
Indicator
IRMD
WVE
Relative Strength Index (RSI) 42.18 53.05
Support Level $90.96 $5.49
Resistance Level $97.63 $6.21
Average True Range (ATR) 3.10 0.25
MACD -0.50 0.03
Stochastic Oscillator 18.99 83.54

Price Performance

Historical Comparison
IRMD
WVE

About IRMD iRadimed Corporation

iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: